ellipticine has been researched along with Glioblastoma in 1 studies
ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
Excerpt | Relevance | Reference |
---|---|---|
"U87MG glioblastoma cell proliferation was efficiently inhibited by ellipticine." | 7.75 | Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells. ( Dontenwill, M; Frei, E; Martinkova, E; Stiborova, M, 2009) |
"U87MG glioblastoma cell proliferation was efficiently inhibited by ellipticine." | 3.75 | Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells. ( Dontenwill, M; Frei, E; Martinkova, E; Stiborova, M, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Martinkova, E | 1 |
Dontenwill, M | 1 |
Frei, E | 1 |
Stiborova, M | 1 |
1 other study available for ellipticine and Glioblastoma
Article | Year |
---|---|
Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells.
Topics: Antineoplastic Agents; Autoradiography; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cel | 2009 |